Two out of Three Women Between 30 and 49 Years of Age Have Never Been Screened for Cervical Cancer
A new study produces comparable estimates of screening coverage for 202 countries and territories
2022
AtG Therapeutics completes a seed financing round raising more than half a million euros
The spin-off that emerged from IDIBELL and the Catalan Institute of Oncology is developing new therapeutic alternatives for advanced cancers and a screening system for these patients.
AtG Therapeutics completes a seed financing round raising more than half a million euros Read More »
White adipose tissue is the most vulnerable to metabolic changes caused by obesity
The study, based on an animal experimental model, shows that when physiological stress exceeds the capacity of white adipose tissue to respond, it reaches a point of no return where it loses its metabolic plasticity.
White adipose tissue is the most vulnerable to metabolic changes caused by obesity Read More »
A model that improves screening of colorectal cancer has been developed
The study, led by researchers from IDIBELL, ICO and Hospital Clínic-IDIBAPS, analyzes the genetic variants associated with the risk of developing the cancer and should make it possible to reduce the number of unnecessary colonoscopies.
A model that improves screening of colorectal cancer has been developed Read More »
A Josep Maria Aran’s project financed by CaixaResearch Validate grants
These grants promote the creation of new products and companies in life sciences and health, as well as help transfer the research results to society and the market.
A Josep Maria Aran’s project financed by CaixaResearch Validate grants Read More »
The Clinical Research and Clinical Trials Unit obtains the ISO 9001:2015 recertification
The IDIBELL Clinical Research and Clinical Trials Unit (UICEC), managed by the HUB’s Clinical Pharmacology service and led by the head of this service, Dr. Pilar Hereu, achieved recertification of the quality management system.
The Clinical Research and Clinical Trials Unit obtains the ISO 9001:2015 recertification Read More »
The association for epilepsy “If I can, you too #epilep” donates 10,000 euros to research
The funds will be directed to the IDIBELL and Bellvitge Hospital research group in Neurological Diseases and Neurogenetics.
Researchers describe genetic variants that increase vulnerability to gambling addiction
This IDIBELL and Bellvitge Hospital study shows that six variants of the gene family that codes for these factors are closely associated with more vulnerability to gambling addiction.
Researchers describe genetic variants that increase vulnerability to gambling addiction Read More »
The educational tandem of IDIBELL and the Institut Bellvitge closes the academic year having increased the number of activities and students involved
The educational tandem formed by the Institut Bellvitge and IDIBELL has closed the 2021-2022 academic year with the publication of the fifth issue of Life & Science magazine, the project carried out by 3rd year ESO students and which includes all the activities that the educational center carries out with researchers and professionals from IDIBELL.
An MRI could predict patients with epilepsy who would not suffer cognitive impairment with surgery
A study by IDIBELL, Bellvitge Hospital, and the University of Barcelona identifies, through magnetic resonance imaging, significant differences in the connectivity of several subregions of the hippocampus between patients with epilepsy who, after surgery, suffer impairments in verbal learning and those who do not.